Inhibition of Human Neutrophil Functions In Vitro by Multiple Sclerosis Disease-Modifying Therapies

Inhibition of Human Neutrophil Functions In Vitro by Multiple Sclerosis Disease-Modifying Therapies

There is a growing optimism about the potential of new disease-modifying therapies (DMTs) in the management of relapsing-remitting multiple sclerosis (RRMS) patients. However, this initial enthusiasm has been tempered by evidence indicating that multiple sclerosis (MS) patients undergoing DMT may be...

Full description

Bibliographic Details
Main Authors: Sara Scutera, Tiziana Musso, Paola Cavalla, Giorgia Piersigilli, Rosaria Sparti, Sara Comini, Marco Vercellino, Anna Maria Cuffini, Giuliana Banche, Valeria Allizond
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Journal of Clinical Medicine
Subjects:
disease-modifying therapies
multiple sclerosis
neutrophil functions
<i>Klebsiella pneumoniae</i>
Online Access:https://www.mdpi.com/2077-0383/9/11/3542

Internet

https://www.mdpi.com/2077-0383/9/11/3542

Similar Items